Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Up – Here’s What Happened

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX)’s stock price gapped up prior to trading on Thursday . The stock had previously closed at $15.61, but opened at $16.15. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $15.70, with a volume of 738 shares trading hands.

Analysts Set New Price Targets

Several analysts recently weighed in on TLX shares. William Blair upgraded Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research note on Tuesday, November 19th. UBS Group initiated coverage on Telix Pharmaceuticals Limited American Depositary Shares in a research report on Friday, November 15th. They issued a “buy” rating and a $21.00 price objective for the company.

Telix Pharmaceuticals Limited American Depositary Shares Trading Up 0.6 %

The stock has a 50-day simple moving average of $15.61.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.